Glucose Tolerance Test + Continuous Glucose Monitoring for Postpartum High Blood Sugar

Recruiting in Palo Alto (17 mi)

+1 other location

Age: 18 - 65

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Alabama at Birmingham

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial uses a device to track blood sugar levels in women who had diabetes during pregnancy. These women are at high risk for developing type 2 diabetes later. The study aims to understand their blood sugar patterns after childbirth and improve screening methods for diabetes.

Eligibility Criteria

This trial is for women who had gestational diabetes during a single pregnancy with no fetal anomalies, diagnosed before 20 weeks or at/after 24 weeks and required medication. It's not for those with skin conditions affecting glucose monitor use, history of prediabetes, PCOS, or pregestational type 2 diabetes.

Inclusion Criteria

I was diagnosed with gestational diabetes before 20 weeks of pregnancy and needed medication.

I was diagnosed with gestational diabetes needing medication after 24 weeks of pregnancy.

I am 34-40 weeks pregnant with one healthy baby.

Exclusion Criteria

I cannot wear a glucose monitor due to skin conditions.

I have had type 2 diabetes before becoming pregnant.

I have a history of prediabetes or polycystic ovarian syndrome.

Participant Groups

The study tests how well two methods can track blood sugar levels after childbirth in women at risk for long-term high blood sugar. One method is a standard oral glucose tolerance test; the other uses a Dexcom G6 Pro continuous glucose monitor.

1Treatment groups

Experimental Treatment

Group I: Postpartum GDMExperimental Treatment1 Intervention

Women with GDM diagnosed early (\< 20 weeks gestation) or with routine 3rd trimester screening (\>=24 weeks) will be enrolled in this longitudinal study. All enrolled women will complete a oral glucose tolerance test and wear a continuous glucose monitor for 10 days at the 3 designated study time points (0-4 days, 4-6 weeks, and 6 months after delivery).